Capitol Health Limited

ASX:CAJ Stock Report

Market Cap: AU$410.4m

Capitol Health Valuation

Is CAJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CAJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CAJ (A$0.39) is trading above our estimate of fair value (A$0.33)

Significantly Below Fair Value: CAJ is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CAJ?

Key metric: As CAJ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CAJ. This is calculated by dividing CAJ's market cap by their current revenue.
What is CAJ's PS Ratio?
PS Ratio1.7x
SalesAU$234.82m
Market CapAU$410.44m

Price to Sales Ratio vs Peers

How does CAJ's PS Ratio compare to its peers?

The above table shows the PS ratio for CAJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
IDX Integral Diagnostics
1.5x15.4%AU$701.7m
ACL Australian Clinical Labs
1x4.7%AU$685.1m
HLA Healthia
1xn/aAU$252.1m
HLS Healius
0.6x-4.8%AU$991.2m
CAJ Capitol Health
1.7x6.4%AU$410.4m

Price-To-Sales vs Peers: CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (1.2x).

Price to Sales Ratio vs Industry

How does CAJ's PS Ratio compare vs other companies in the AU Healthcare Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
FCG Freedom Care Group Holdings
0.1xn/aUS$2.51m
HHI Health House International
0.05xn/aUS$590.30k
TTB Total Brain
0.03xn/aUS$179.68k
No more companies available in this PS range
CAJ 1.7xIndustry Avg. 1.3xNo. of Companies3PS00.81.62.43.24+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the Oceanic Healthcare industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is CAJ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CAJ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.7x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: CAJ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CAJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
AU$0.32
0%
4.8%AU$0.33AU$0.29n/a8
Dec ’25AU$0.36
AU$0.32
-13.0%
4.8%AU$0.33AU$0.29n/a8
Nov ’25AU$0.36
AU$0.32
-11.8%
4.8%AU$0.33AU$0.29n/a8
Oct ’25AU$0.36
AU$0.31
-13.0%
6.0%AU$0.33AU$0.28n/a9
Sep ’25AU$0.32
AU$0.31
-0.5%
6.0%AU$0.33AU$0.28n/a9
Aug ’25AU$0.30
AU$0.29
-4.5%
8.2%AU$0.33AU$0.27n/a9
Jul ’25AU$0.30
AU$0.29
-2.9%
8.2%AU$0.33AU$0.27n/a9
Jun ’25AU$0.24
AU$0.29
+16.6%
7.4%AU$0.32AU$0.27n/a8
May ’25AU$0.24
AU$0.28
+15.7%
7.2%AU$0.32AU$0.27n/a7
Apr ’25AU$0.24
AU$0.28
+18.2%
7.2%AU$0.32AU$0.27n/a7
Mar ’25AU$0.27
AU$0.28
+4.1%
8.4%AU$0.32AU$0.25n/a7
Feb ’25AU$0.26
AU$0.27
+6.8%
7.5%AU$0.30AU$0.25n/a7
Jan ’25AU$0.23
AU$0.27
+14.7%
7.8%AU$0.30AU$0.24n/a8
Dec ’24AU$0.21
AU$0.27
+28.4%
7.8%AU$0.30AU$0.24AU$0.368
Nov ’24AU$0.19
AU$0.27
+43.2%
6.7%AU$0.30AU$0.25AU$0.368
Oct ’24AU$0.21
AU$0.28
+31.1%
7.0%AU$0.30AU$0.25AU$0.369
Sep ’24AU$0.23
AU$0.29
+27.4%
13.6%AU$0.39AU$0.25AU$0.3210
Aug ’24AU$0.23
AU$0.30
+29.8%
10.4%AU$0.39AU$0.27AU$0.3010
Jul ’24AU$0.27
AU$0.31
+16.5%
10.4%AU$0.39AU$0.28AU$0.3011
Jun ’24AU$0.28
AU$0.33
+17.5%
9.4%AU$0.39AU$0.28AU$0.2410
May ’24AU$0.28
AU$0.33
+19.6%
9.9%AU$0.39AU$0.28AU$0.249
Apr ’24AU$0.27
AU$0.33
+23.0%
10.8%AU$0.39AU$0.28AU$0.249
Mar ’24AU$0.27
AU$0.33
+23.1%
11.1%AU$0.39AU$0.28AU$0.278
Feb ’24AU$0.28
AU$0.39
+36.4%
10.9%AU$0.43AU$0.31AU$0.267
Jan ’24AU$0.32
AU$0.39
+21.5%
10.9%AU$0.43AU$0.31AU$0.237
Dec ’23AU$0.32
AU$0.39
+23.0%
11.2%AU$0.43AU$0.31AU$0.216

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/11 03:18
End of Day Share Price 2024/12/11 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Capitol Health Limited is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Anubhav SaxenaBell Potter
Martyn JacobsBell Potter